North America Cell and Gene Therapy Contract Development and Manufacturing Organization Market Driven by Biotechnology Innovation
The increasing adoption of advanced therapies, growing investments in biotechnology research, and rising demand for specialized manufacturing services are significantly accelerating the growth of the North America Cell and Gene Therapy Contract Development and Manufacturing Organization Market. Pharmaceutical and biotechnology companies are increasingly outsourcing development and manufacturing activities to contract organizations to reduce operational costs, improve scalability, and speed up commercialization timelines. The market is gaining strong momentum due to the rapid expansion of regenerative medicine and personalized therapies across the United States and Canada.
The North America Cell and Gene Therapy Contract Development and Manufacturing Organization Market Outlook remains highly promising as the sector continues to witness technological advancements, increasing regulatory approvals, and rising clinical trial activity. The North America Cell and Gene Therapy Contract Development and Manufacturing Organization Market size is expected to reach US$ 15,571.7 million by 2031 from US$ 3,012.9 million in 2024. The market is estimated to record a CAGR of 26.6% from 2025 to 2031, highlighting strong long-term growth opportunities for service providers, biotech innovators, and investors operating in the region.
Explore more: https://www.theinsightpartners.....com/reports/north-a